Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles

被引:162
作者
Missirlis, Dimitrios
Kawamura, Ryuzo
Tirelli, Nicola
Hubbell, Jeffrey A.
机构
[1] Ecole Polytech Fed Lausanne, Inst Bioengn, SV IBI LMRP, CH-1015 Lausanne, Switzerland
[2] Swiss Fed Inst Technol, Dept Mat, CH-8044 Zurich, Switzerland
[3] Swiss Fed Inst Technol, Inst Biomed Engn, CH-8044 Zurich, Switzerland
[4] Univ Zurich, CH-8044 Zurich, Switzerland
[5] Univ Manchester, Sch Pharm, Manchester M13 9PL, Lancs, England
[6] Univ Manchester, Mol Mat Ctr, Manchester M13 9PL, Lancs, England
关键词
poloxamer; delivery system; inverse emulsion; photopolymerization; hydrophobic interactions;
D O I
10.1016/j.ejps.2006.06.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have recently described the preparation of stable, polymeric nanoparticles, composed of poly(ethylene glycol) and poloxamer 407 (Pluronic (R) F127), prepared via inverse emulsion photopolymerization. In the present study we report on the performance of this novel colloidal system as a controlled delivery system for small hydrophobic drugs. Successful encapsulation of doxorubicin occurred through hydrophobic interactions, taking advantage of particle nanoarchitecture. Loadings of up to 8.7 wt.% were achieved with a reproducible, fast, solvent evaporation procedure. In vitro drug release, monitored by fluorescence spectrometry and HPLC, revealed a minor burst (approximately 10% at 37 degrees C) and sustained, diffusional release for over 1 week; furthermore, drug encapsulation significantly delayed doxorubicin degradation kinetics. (c) 2006 Published by Elsevier B.V.
引用
收藏
页码:120 / 129
页数:10
相关论文
共 39 条
[1]   Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials [J].
Alakhov, V ;
Klinski, E ;
Li, SM ;
Pietrzynski, G ;
Venne, A ;
Batrakova, E ;
Bronitch, T ;
Kabanov, A .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :113-134
[2]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[3]   Ligand-targeted therapeutics in anticancer therapy [J].
Allen, TM .
NATURE REVIEWS CANCER, 2002, 2 (10) :750-763
[4]   Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: Tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy [J].
Bae, Y ;
Nishiyama, N ;
Fukushima, S ;
Koyama, H ;
Yasuhiro, M ;
Kataoka, K .
BIOCONJUGATE CHEMISTRY, 2005, 16 (01) :122-130
[5]   ASPECTS OF THE DEGRADATION KINETICS OF DOXORUBICIN IN AQUEOUS-SOLUTION [J].
BEIJNEN, JH ;
VANDERHOUWEN, OAGJ ;
UNDERBERG, WJM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 32 (2-3) :123-131
[6]  
Cellesi F, 2002, MACROMOL CHEM PHYSIC, V203, P1466, DOI 10.1002/1521-3935(200207)203:10/11<1466::AID-MACP1466>3.0.CO
[7]  
2-P
[8]   PARTICLE SIZING BY QUASI-ELASTIC LIGHT-SCATTERING [J].
FINSY, R .
ADVANCES IN COLLOID AND INTERFACE SCIENCE, 1994, 52 :79-143
[9]   Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies [J].
Gabizon, A ;
Shmeeda, H ;
Barenholz, Y .
CLINICAL PHARMACOKINETICS, 2003, 42 (05) :419-436
[10]   pH-responsive copolymer assemblies for controlled release of doxorubicin [J].
Gillies, ER ;
Fréchet, JMJ .
BIOCONJUGATE CHEMISTRY, 2005, 16 (02) :361-368